Gun Anker

Influence of Letrozole and Anastrozole on Total Body Aromatization and Plasma Estrogen Levels in Postmenopausal Breast Cancer Patients Evaluated in a Randomized, Cross-Over Study

Jürgen Geisler, Ben P. Haynes, Gun Anker et al. · Journal of Clinical Oncology · 2002 · 575 citations

Medicine, Oncology, Pharmacology +17

Tailored fluorouracil, epirubicin, and cyclophosphamide compared with marrow-supported high-dose chemotherapy as adjuvant treatment for high-risk breast cancer: a randomised trial

Jonas Bergh, Tom Wiklund, Björn Erikstein et al. · The Lancet · 2000 · 342 citations

Medicine, Oncology, Pharmacology +17

In vivo inhibition of aromatization by exemestane, a novel irreversible aromatase inhibitor, in postmenopausal breast cancer patients.

Jürgen Geisler, Nicholas King, Gun Anker et al. · PubMed · 1998 · 316 citations

Medicine, Endocrinology, Pharmacology +17

High-dose estrogen treatment in postmenopausal breast cancer patients heavily exposed to endocrine therapy

Per Eystein Lønning, Paul Taylor, Gun Anker et al. · Breast Cancer Research and Treatment · 2001 · 226 citations

Medicine, Endocrinology, Oncology +14

TP53 gene mutations predict the response to neoadjuvant treatment with 5-fluorouracil and mitomycin in locally advanced breast cancer.

Stephanie Geisler, Anne‐Lise Børresen‐Dale, Hilde Johnsen et al. · PubMed · 2003 · 154 citations

Medicine, Oncology, Pharmacology +14